Clinical Trial Update: Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial investigated temozolomide for stage IIIB/IV or recurrent non-small cell lung cancer and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED